XTalks
JULY 29, 2024
Orphan drug development poses many challenges that are unique to rare diseases, including recruitment in small patient populations, variable progression with heterogenous clinical manifestations and limited understanding of disease progression and natural history.
XTalks
DECEMBER 1, 2020
With this has come an increase in the size of the global clinical trials market, with an estimated worth of around $46.8 The lab has processed over 25,000 samples, participated in almost 60 clinical trials, and has partnered with over 25 different pharmaceutical companies. trillion, with oncologics accounting for $99.5
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
MARCH 13, 2023
Who better than people living with a condition to inform drug companies, physicians, academics, and the FDA on what it is like to live with their condition, what symptoms most impact their lives, what goes into their decision about whether to participate in a clinical trial, and what kind of treatment effects would be most meaningful to them?
XTalks
MARCH 7, 2024
Experts discuss the therapeutic landscape, treatment gaps, regulatory considerations and clinical trial strategies. The webinar provides insights into a novel method that facilitates detailed genetic analysis of breast cancer, marrying the depth of whole-genome studies with the precision of targeted analysis at the single-cell level.
The Pharma Data
DECEMBER 11, 2020
Bhavana Bhatnagar, an Ohio State University (OSU) cancer specialist and lead author of the second study, “Access can potentially be an issue, in terms of being able to get to tertiary care centers that have clinical trial availability and physicians who have disease-specific expertise in treating some of these rarer cancers.
The Pharma Data
SEPTEMBER 3, 2020
Our findings could help to pick out those patients most likely to benefit from immunotherapy – and we’re keen to translate our work into clinical trials to test the benefit of different immunotherapeutic strategies to tackle this hard-to-treat form of pancreatic cancer.”. Source link.
pharmaphorum
NOVEMBER 16, 2022
Asked to elucidate the specifics of what the study had found, Dr Wykoff’s positivity over the “large, global clinical trial” was palpable; certainly, he is deeply passionate about his specialist area. “To To dive into specifics, […] OAKS and DERBY were identical trials. The specifics of an exciting prospect. Dr Charles C.
Expert insights. Personalized for you.
105 
Let's personalize your content